Schizophrenia - Treatment 2 (drugs) Flashcards
What are the typical antipsychotics? What are they classed on?
phenothiazines
- chlorpromazine
- thioridazine (high anti-muscarinic potential)
haloperidol
flupentixol
sulpiride
fluphenazine
How do the typical antipsychotics work? What are their benefits and side effects?
chlorpromazine
- has anti-muscarinic properties therefore less extrapyramidal effects, very sedative (D2/H1)
thioridazine
- has anti-muscarinic properties and is rarely associated with movement disorders, cause sexual dysfunction, not sedative (no H1)
haloperidol
- no anti-muscarinic properties, has high incidence of motor disorders
flupentixol
fluphenazine (depot)
sulpiride
- selective D2 antagonism to the mesolimbic pathway, fewer motor effects, little sedation
What are the atypical antipsychotics?
clozapine
olanzapine
risperidone
aripiprazole
How do the atypical antipsychotics work? What are their benefits and side effects?
clozapine
- no EPSe as its highly specific for D2 receptors in the mesolimbic pathway and has fast dissociation
- high D4 blocking activity
- side effects: weight gain, neutropenia, agranulocytosis
olanzapine
risperidone
- no anti-muscarinic properties (no M1 binding), no EPSE at lower doses but is seen at higher doses
- 5-HT2 antagonism and D2 antagonism (stronger than clozapine)
aripiprazole
What are the common side effects of typical antipsychotics?
movement disorders/extrapyramidal side effects (EPSE)
- parkinsonian = tremor, slow movement, muscle stiffness
- dystonia = muscles contract involuntarily, causing repetitive or twisting movements
- tardive dyskinesia = sudden, irregular facial and body movements (develops after chronic use and is irreversible)
breast swelling (gynaecomastia) lactation
decreased pleasure
- apathy
sedation
- inhibition of aggression (D2/H1)
weight gain
photosensitisation
What are the common side effects of atypical antipsychotics?
fewer EPSE and movement disorders
increased QT interval (ziprasidone)
increased risk of myocardial infarction/stroke
What problems do patients have with antipsychotics? How can these be solved?
mainly effective against positive symptoms but is limited for negative symptoms
limited improvement for most patients
no improvement for some patients even with prolonged therapy
relapse common in drug-maintained patients
compliance
compliance
- longer acting antipsychotics means they can be taken less frequently (orally or i.m.)
- can be taken as depot injections
= i.m injections of oily suspensions increase duration of effectiveness and compliance
e.g. fluphenazine
What are the options for future drug development?
drugs which increase glutamate, NMDA and AMPA activity
- glutamate theory suggests that low Glu in the frontal cortex is associated with negative symptoms
agonists of metabotropic glutamate receptors
drugs which dissociate from D2 receptors quickly
drugs which
- decrease D2 activity in the mesolimbic
- have no D2 effect in the nigrostriatal
- increase D2 effect in the mesocorticol